1. Home
  2. SPNS vs ADPT Comparison

SPNS vs ADPT Comparison

Compare SPNS & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPNS
  • ADPT
  • Stock Information
  • Founded
  • SPNS 1982
  • ADPT 2009
  • Country
  • SPNS Israel
  • ADPT United States
  • Employees
  • SPNS N/A
  • ADPT N/A
  • Industry
  • SPNS Computer Software: Prepackaged Software
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SPNS Technology
  • ADPT Health Care
  • Exchange
  • SPNS Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • SPNS 2.4B
  • ADPT 2.6B
  • IPO Year
  • SPNS 1992
  • ADPT 2019
  • Fundamental
  • Price
  • SPNS $43.20
  • ADPT $13.95
  • Analyst Decision
  • SPNS Hold
  • ADPT Strong Buy
  • Analyst Count
  • SPNS 3
  • ADPT 10
  • Target Price
  • SPNS $31.33
  • ADPT $16.60
  • AVG Volume (30 Days)
  • SPNS 373.4K
  • ADPT 1.8M
  • Earning Date
  • SPNS 11-13-2025
  • ADPT 11-05-2025
  • Dividend Yield
  • SPNS 1.39%
  • ADPT N/A
  • EPS Growth
  • SPNS N/A
  • ADPT N/A
  • EPS
  • SPNS 1.15
  • ADPT N/A
  • Revenue
  • SPNS $564,331,000.00
  • ADPT $252,754,000.00
  • Revenue This Year
  • SPNS $8.50
  • ADPT $36.43
  • Revenue Next Year
  • SPNS $6.83
  • ADPT $12.31
  • P/E Ratio
  • SPNS $37.57
  • ADPT N/A
  • Revenue Growth
  • SPNS 4.71
  • ADPT 42.57
  • 52 Week Low
  • SPNS $23.69
  • ADPT $4.27
  • 52 Week High
  • SPNS $43.25
  • ADPT $17.89
  • Technical
  • Relative Strength Index (RSI)
  • SPNS 71.74
  • ADPT 35.21
  • Support Level
  • SPNS $43.05
  • ADPT $14.26
  • Resistance Level
  • SPNS $43.28
  • ADPT $15.05
  • Average True Range (ATR)
  • SPNS 0.06
  • ADPT 0.81
  • MACD
  • SPNS -0.05
  • ADPT -0.46
  • Stochastic Oscillator
  • SPNS 67.31
  • ADPT 7.89

About SPNS Sapiens International Corporation N.V. (Cayman Islands)

Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: